Blackstone (BX) Explores $2 Billion Sale of ZO Skin Health
Published on · Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowBlackstone Inc. (NYSE: BX) is considering a sale of ZO Skin Health, which may be valued at approximately $2 billion. This potential sale is in early stages, with Blackstone collaborating with Citigroup and Raymond James. The interest stems from a growing demand for clinically positioned skincare brands that are sold through professionals, offering a premium image. A successful sale could not only provide significant cash for Blackstone but also indicate strength in its consumer healthcare strategy, benefiting investors as it demonstrates effective business growth and value realization.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Citigroup Inc. (C)
Citigroup is a global bank with consumer and institutional operations across many countries.
The Financials sector covers banks, insurers and capital-markets firms at the center of the economy.
Earlier C news
- SpaceX Stock Target of $12 Trillion by Citigroup Amid AI Boom
- Anthropic Plans $100 Billion IPO Amid AI Risks
- Citi, HSBC, StanChart Adopt Ant International’s Forex AI Tool
- Citigroup (C) Appoints Adam Clark as Wealth Planning Head
- EPAM Systems (EPAM) Stock Soars 17.5% on AI Collaboration
Understand this kind of story
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
